Nacimbio holding has completed the first stage of vaccine supply under the National Immunization Schedule. Russian regions have received drug products for protection against pertussis, tetanus, diphtheria, hepatitis B, tuberculosis and rubella.
Preventive preparations are delivered under public contracts made in 2024 between Nacimbio holding and Federal Center for Planning and Management of Medicine Provision of the Ministry of Health of the Russian Federation. The first delivery batch included 8.48 million vaccine doses.
“The first stage of vaccine and toxoid supply for the National Immunization Schedule has been completed. The drug products have been delivered to Russian regions in due time and volume as specified in the public contract, moreover, rubella vaccines have been supplied two weeks ahead of the schedule. Supplies will be continued during the year as far as new public contracts are concluded,” said Andrey Zagorsky, General Director of Nacimbio.
In addition, Vaktrivir combined measles, rubella, parotitis live vaccine is also promptly delivered to Russian regions in 2024. Nacimbio holding produced and delivered more than 473,000 doses of this drug from the beginning of the year to 15 March.
